Proﬁle of Japan Bioindustry Association

Message from Chairperson

Charting a path for next-generation
bio-industries
On June 11 of 2019, the government ﬁnalized what it calls

Bioeconomy Strategy 2019: Building Biocommunities which attract

respect from both domestic and oversea people. This strategy ispositioned as an international strategy for creating businesses thatuse biotechnologies and sets forth four visions for society and ninemarket sectors to be realized.

Up until now, biotechnologies have coexisted with the life sciences
and contributed to the growth of various industrial sectors,
including pharmaceuticals, medical care, and healthcare;chemicals, materials, and energy; provisions, foodstuﬀ, and primaryindustries; and the environment and life sector. Intended targets
include fermentation, selective breeding, cell fusion, generecombination, biomedicine, bio-pesticides, bio-chemicals,bioreactors, bioenergy, regenerative medicine, and genediagnostics.

In recent years, however, various issues haveWith a membership comprising representatives

concerning food supplies, an aging society,academia, the Japan Bioindustry Association is

emerged on a global scale, including those

health, illnesses, diseases, the environment, andresources. There are growing expectations that
bio-industries will be able to signiﬁcantly
revolutionize these societal systems. For

example, bio-industries that can help Japan, theworldʼs biggest super-aging society, establish asociety of health and longevity in which

quality-of-life (QOL) standards are met willcollectively constitute a model for international
markets. For this reason, people would like to

see a cross-fertilization of biotechnologies anddigital sciences. In other words, our strategy isfrom the worlds of industry, government, andtasked with promoting innovations in theoriginal areas of biotechnology that are uniqueto traditional Japan and helping establish
industries that will contribute to systems

harnessed by international society. Activities

carried out by the Japan Bioindustry Association

for the cultivation of both human resources andindustries are expected to be key for therealization of these goals. I am committed torendering service to the best of my abilities as
the chairperson of this organization.

to shake up societal systems by having digitalsciences serve as a go-between and bringindividual heterogeneous bio-industries

together. In a manner of speaking, we aretalking about interactions between “cis” and“trans.”

Dr. Keiko AbeChairperson,

Japan Bioindustry Association

Policy
Proposals andDialogues
AdvancedBiotechnology
Agora

Discovery of Seeds/
Commercialization
Cooperation of the government,
industry, and academia

Promotion ofbio-related policies● Implementation of Japanʼs

Bioeconomy strategy● Policy dialogues(such as adaptation toNagoya Protocol)● Seminars for providing information

on advanced biotechnology● Study group activities● R&D project designJBAʼs 5 Actions

Promotion ofOpen Innovation
Cooperation withcompanies, support ofbusiness ventures● Business seminars● Support of collaboration

among bio-related parties

GlobalNetworkingand Framework
CreationTransmitting overseas
biotechnology news andbio-related events● Global cooperation-related

seminars, BioJapan● Members' communication

Bioindustry
Infrastructure
Establishment
Enhancement ofworking group activities● Acceleration of new technology

implementation● Intellectual property committee activities● Biotechnology humanresources development● Raising awareness of access tooverseas genetic resources
and beneﬁt sharing

Overseas bio-organizations havingagreements with JBAAsiaEurope● Hong Kong

● Flanders (Belgium) ● Wallonia (Belgium)● Taiwan● Finland ● France ● Germany ● Ireland

Industries Association(since 2005)● KoreaBIO (since 2012)● Medical and PharmaceuticalCommercial Association,
All-China Federation of Industry
and Commerce (since 2012)● Taiwan Bio Industry Organization(since 2012)● New Taipei City Bio Technology
Alliance (since 2015)● EU ● Austria ● Brussels (Belgium)● Malaysia● the Czech Republic ● Denmark ● Estonia● Shanghai Biopharmaceutics● Lithuania ● the Netherlands ● Spain● Catalonia (Spain) ● Sweden ● Switzerland● UK ● Scotland (UK)● Swiss Biotech Association (since 2005)● Russian Biotechnology Society (since 2009)● CLIB2021(Bioclusters of the Rhein Region)/Cluster Bioindustrielle
Biotechnologie (since 2009)● DECHEMA (since 2010)● Medicon Valley Alliance(Denmark/Sweden) (since 2012)● SwedenBIO (since 2013)● Life Science Austria (since 2013)● Eurasante (France) (since 2014)● Biovalley France/Former Alsace Biovalley(France)（since 2014）● Enterprise Lithuania (Lithuania) (since 2015)● ASEBIO (Spain) (since 2016)● FlandersBio (Belgium) (since 2016)

Oceania● Australia● Queensland (Australia)● Victoria (Australia)● AusBiotech (since 2013)● Life Sciences Queensland (since 2015)

Creation ofInternational Network
JBA provides international information on biotechnology andbioindustry in cooperation with member companies,universities, and the government.

●…JBA members (38 organizations as of September 2020)●…Overseas biotechnology organizations with which JBA has written agreements (as of September 2020)

CanadaUnited States● Canada● Alberta● US● Ontario● Georgia● Florida● British Columbia● Iowa● Quebec● North Carolina● Michigan● Pennsylvania● BIO (since 2004)● Biocom (since 2014)

Japanese bioclusters having relationshipwith JBA international network hub(All Japanese Bio Regions Committee)● Hokkaido Bio-Industry Association● Northern Advancement Centerfor Science & Technology● Hokkaido Association for

Bio-Business● Kumamoto Industrial Support

Foundation● Foundation for Biomedical Researchand Innovation at Kobe

● Kinki Bio-Industry Development● Kurume Research Park

Organization● Senri Life Science Foundation● Kihara Memorial Yokohama

Foundation for The
Advancement of Life Sciences● Osaka Bio Headquarters● Shikoku Industry & TechnologyPromotion Center● Okinawa Industry Promotion

Public Corporation● The Mt. Fuji Foundation forHealthcare Innovation and Cluster
Development Pharma
Valley CenterAcceleration ofOpen Innovation

Asiaʼs
No.1PartneringEvent!

JBA provides opportunities to help thedevelopment of biotechnologyand industry.

Exhibition

Partnering

Environment/
EnergyFoods

Seminar

Diagnosis/
Medical devices

Collaborative research

Health care

Licensing in and out

Business partnerships

Medicine/Medical

Creating innovation in fusional areas

Research tools

JBA holds the partnering bio event BioJapan, the Regenerative Medicine Japan andthe healthTECH JAPAN as key business platforms.

Implementation of Japanʼs
Bioeconomy Strategy
The Japanese bioeconomy strategy, formulated in 2019with JABEX, has promoted the activities of voluntaryadvanced bioeconomy society in 2030, with “Bio-ﬁrst

the Government. JBA/JABEX will contribute to the socialand revised in 2020, aims to establish the world's mostcompanies which shape roadmaps and present them toconcept”, formation of “Bio-community”, and “Bioimplementation of the bioeconomy straregy throughdata-driven”. In detail, four social visions and nine

the participation of the revision and execution of themarket domains are set to achive the strategy, and theroadmaps in the strategy, the establishment of theexpansion of each market domains are promoted with

bio-community area, the bio data linkage, and so on.

roadmaps that are updated every year. JBA, together

Social Visions and market domains determined by the Bioeconomy Strategy

Four social visions
Circular society thatcoordinates allindustries

Society engaged insustainable primary
production able to satisfy
diverse needs

Society that uses
sustainable production
methods to create
biomaterials and biobased components

Society in which medicine
and non medical healthcare coordinate to enable
long, active socialparticipation

Nine market domains① High-function bio-materials ( lightweight, durable, safe )② Bioplastic ( general plastic substitutes )③ Sustainable primary production system④ Organic waste and organic wastewater treatment⑤ Lifestyle improvement-focused healthcare, functional foods, and digital health⑥ Related industry in bio pharmaceuticals, regenerative medicine, celluler treatment, and genetic treatment⑦ Bio production system < Industry and food production related (production using biological functions)>⑧ Bio-related analysis, measurement, and experiment systems⑨ Large wooden structures and smart forestry

Support for Internal Bio-Venture
Companies and Bio-Clusters
Giving support to bio-ventures,and collaborative activities
among bio-related parties

Conference ofbio-related parties

BioclustersummitExchanges and cooperation amongindustry, academia and government
are promoted through informationexchanges and cooperative activities
utilizing JBAʼs network linking
biotechnology organizations andclusters all over Japan.

The conference considered thestrengthening of the network linking
the primary organizations forindustry-government-academia
cooperation in biotechnology in all
the regions of Japan. It sharesinformation among theseorganizations, and future guidelines,
with the aim of establishinga system where these organizations
cooperate closely.

Biotechnology organizations fromvarious countries gather in Japan tohave deep discussions on the spiritof entrepreneurship, securing corehuman resources, and the importanceof the formation of networks
among companies and amongentrepreneurs.

About JBA
History

Members

Board of Directors

JBAʼs roots date back to Shusei Kyokai(the Distilled Spirits Institute)establishedin 1942.
Its name, after being changed to theJapanese Association of IndustrialFermentation, was renamed as JapanBioindustry Association (JBA)
in 1987.

Corporate members: 279 companies(pharmaceutical, food, chemical,cosmetic and machinery companies)
Public members: 131 organizations
Individual members: approx. 600(university and corporate researchers)(As of September 2020)

Chairperson
Keiko Abe
Project Professor,
Graduate School of Agricultural andLife Sciences,
The University of Tokyo
President
Osamu Nagayama
Senior Advisor and Honorary Chairman,
Chugai Pharmaceutical Co., Ltd.
Executive Director
Yoshiaki Tsukamoto

AccessJapan Bioindustry Association
Grande Bldg. 8F,
2-26-9 Hatchobori, Chuo-ku,
Tokyo 104-0032, Japan
Tel +81-3-5541-2731 Fax +81-3-5541-2737
URL https://www.jba.or.jp/
September 2020